يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Röcken, Martin"', وقت الاستعلام: 0.59s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Universitätsklinikum Tübingen - University Hospital of Tübingen, Eberhard Karls Universität Tübingen = Eberhard Karls University of Tuebingen, Organisation Nucléaire et Oncogenèse / Nuclear Organization and Oncogenesis, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Equipe labellisée Ligue contre le Cancer, This work was supported by the Wilhelm Sander Foundation (2012.056.3 to M.R.), German Cancer Aid (application numbers 109037 and 110664 to M.R.), and German Research Association (TRR-SFB 156, DFG RO 764/14-1 and DFG RO 764/15-2 to M.R. and DFG WI 1279/4-1 to T.W.). The group of O.B. is supported by grants from ANR-BMFT, Fondation ARC pour la recherche sur le Cancer, INSERM, and the National Cancer Institute of the National Institutes of Health under Award Number R01CA136533. O.B. is a CNRS Research Director DR2.We acknowledge support by Deutsche Forschungsgemeinschaft and open Access Publishing Fund of University of Tübingen, Martin Röckenand Thomas Wieder share senior authorship. The authors would like to thank S. Weidemann and V. Galinat for expert technical assistance.

    المصدر: ISSN: 1015-8987.

  2. 2
    دورية أكاديمية

    المساهمون: Universitätsklinikum Tübingen - University Hospital of Tübingen, Eberhard Karls Universität Tübingen = Eberhard Karls University of Tuebingen, Organisation Nucléaire et Oncogenèse / Nuclear Organization and Oncogenesis, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Equipe labellisée Ligue contre le Cancer, This work was supported by the Wilhelm Sander Foundation (2012.056.3 to M.R.), German Cancer Aid (application numbers 109037 and 110664 to M.R.), and German Research Association (TRR-SFB 156, DFG RO 764/14-1 and DFG RO 764/15-2 to M.R. and DFG WI 1279/4-1 to T.W.). The group of O.B. is supported by grants from ANR-BMFT, Fondation ARC pour la recherche sur le Cancer, INSERM, and the National Cancer Institute of the National Institutes of Health under Award Number R01CA136533. O.B. is a CNRS Research Director DR2.We acknowledge support by Deutsche Forschungsgemeinschaft and open Access Publishing Fund of University of Tübingen, Martin Röckenand Thomas Wieder share senior authorship. The authors would like to thank S. Weidemann and V. Galinat for expert technical assistance.

    المصدر: ISSN: 1015-8987.

  3. 3
    دورية أكاديمية

    المساهمون: Universitätsklinikum Tübingen - University Hospital of Tübingen, Eberhard Karls Universität Tübingen = Eberhard Karls University of Tuebingen, Organisation Nucléaire et Oncogenèse / Nuclear Organization and Oncogenesis, Institut Pasteur Paris -Institut National de la Santé et de la Recherche Médicale (INSERM), Equipe labellisée Ligue contre le Cancer, This work was supported by the Wilhelm Sander Foundation (2012.056.3 to M.R.), German Cancer Aid (application numbers 109037 and 110664 to M.R.), and German Research Association (TRR-SFB 156, DFG RO 764/14-1 and DFG RO 764/15-2 to M.R. and DFG WI 1279/4-1 to T.W.). The group of O.B. is supported by grants from ANR-BMFT, Fondation ARC pour la recherche sur le Cancer, INSERM, and the National Cancer Institute of the National Institutes of Health under Award Number R01CA136533. O.B. is a CNRS Research Director DR2.We acknowledge support by Deutsche Forschungsgemeinschaft and open Access Publishing Fund of University of Tübingen, Martin Röckenand Thomas Wieder share senior authorship. The authors would like to thank S. Weidemann and V. Galinat for expert technical assistance.

    المصدر: ISSN: 1015-8987.

  4. 4
    دورية أكاديمية